Cargando…
The role of RLAI in early schizophrenia treatment: critical aspects regarding efficacy and safety
Autor principal: | Papageorgiou, George |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991983/ http://dx.doi.org/10.1186/1744-859X-9-S1-S69 |
Ejemplares similares
-
European Treatment Guidelines for schizophrenia
por: Gaebel, Wolfgang
Publicado: (2010) -
Evaluation safety and efficacy of MRgFUS for palliative treatment of bone metastasis
por: Turkevich, Vladimir, et al.
Publicado: (2014) -
The safety and efficacy of fibrinogen and thrombin-based collagen fleece for treatment of pleural injury
por: Tsubokawa, Norifumi, et al.
Publicado: (2015) -
Why treating early, treating well, and treating for life is important in schizophrenia
por: Kahn, Rene
Publicado: (2010) -
Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
por: Lode, H, et al.
Publicado: (2002)